Navigation Links
TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen
Date:2/15/2017

SAN FRANCISCO, Feb. 15, 2017 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") announced today that it has entered into a license agreement with Janssen Biotech, Inc. (Janssen) for use of The Trianni Mouse, a best-in-class monoclonal antibody discovery platform.

Distinguished by novel chimeric gene segment design, the Trianni platform provides Janssen with access to a complete human antibody repertoire that has been optimized for the rapid isolation of fully-human therapeutics. "We are very pleased with the Janssen decision to adopt the Trianni Mouse," commented Dr. Matthias Wabl, Ph.D., Chairman and CEO of TRIANNI. "With its highly differentiated features, most notably a full human antibody repertoire assembled from gene segments that are under mouse regulatory control, we are confident the platform will prove extremely productive for Janssen."

About Trianni, Inc.
TRIANNI is a privately held organization, formed in 2010 with a mission to use recent advances in DNA synthesis and genomic modification technology for the development of an optimized therapeutic antibody discovery platform, The Trianni Mouse. The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website, www.trianni.com

Contact
Mandy Boyd
Director of Marketing
1.415.231.0256 [o]
1.866.674.9314
mandy.boyd@trianni.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trianni-signs-licensing-agreement-for-transgenic-mouse-platform-use-with-janssen-300407881.html


'/>"/>
SOURCE Trianni, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. TRIANNI Announces Issuance of Russian Federation Patent
2. THC Signs Definitive Agreement to Purchase Clone Shipper
3. AGC Signs Agreement for Acquisition of Leading Biopharmaceutical CDMO, CMC Biologics
4. Fischer resigns as Neogen director
5. Dovetail Genomics Signs Japan Distribution Agreement
6. Craft Beer Pioneer, Lagunitas, Signs Up to Save $22.5M in Water, Wastewater, and Energy Costs with Cambrian Innovation’s WEPA
7. WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership
8. Oncimmune Signs Agreement with Accu Reference
9. Thought-Leading Physician, Dr. David Agus, Signs on to Advise uBiome
10. South Dakota Mines Signs Collaborative Agreement with Harvard Business School
11. Epsilon Signs New Multi-Year Agreement To Provide Global Database Marketing Services For Worldwide Biotechnology Leader Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... ... redesigned, easier-to-navigate website for all six of their healthcare job boards. As ... pharmacists, physical and occupational therapists, and biotechnicians, DocCafe.com and the MedJobCafe.com Health ...
(Date:6/22/2017)... ... June 21, 2017 , ... Building on the success of ... more informative on the very latest developments in radical life extension. RAADfest combines cutting ... festival, and the empowerment of personal development, making it the largest most comprehensive and ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... to clients throughout the biopharma and life sciences industries, continue to be in ... seeing. Tunnell’s Kip Wolf will be speaking on “The State of Information Governance ...
(Date:6/20/2017)... Rocky Hill, CT (PRWEB) , ... June 20, ... ... entrepreneurial support, today announced that the CTNext board of directors has formed a ... developed by a working group composed of institution presidents and other high-ranking representatives ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):